South Korea Anti-infective Agents Market Size & Outlook
South Korea anti-infective agents market, 2018-2030 (US$M)
Related Markets
South Korea anti-infective agents market highlights
- The South Korea anti-infective agents market generated a revenue of USD 1,482.2 million in 2024 and is expected to reach USD 1,541.3 million by 2030.
- The South Korea market is expected to grow at a CAGR of 1.3% from 2025 to 2030.
- In terms of segment, antivirals was the largest revenue generating type in 2024.
- Antibacterials is the most lucrative type segment registering the fastest growth during the forecast period.
Anti-infective agents market data book summary
| Market revenue in 2024 | USD 1,482.2 million |
| Market revenue in 2030 | USD 1,541.3 million |
| Growth rate | 1.3% (CAGR from 2025 to 2030) |
| Largest segment | Antivirals |
| Fastest growing segment | Antibacterials |
| Historical data | 2018 - 2023 |
| Base year | 2024 |
| Forecast period | 2025 - 2030 |
| Quantitative units | Revenue in USD million |
| Market segmentation | Antibacterials, Antivirals, Antifungals |
| Key market players worldwide | Pfizer Inc, Abbott Laboratories, Gilead Sciences Inc, Bristol-Myers Squibb Co, Merck & Co Inc, Sandoz Group AG ADR, B. Braun, Novo Holdings, Mankind Pharma, Bayer AG, AstraZeneca PLC, Boehringer Ingelheim Pharma |
Other key industry trends
- In terms of revenue, South Korea accounted for 1.1% of the global anti-infective agents market in 2024.
- Country-wise, U.S. is expected to lead the global market in terms of revenue in 2030.
- In Asia Pacific, China anti-infective agents market is projected to lead the regional market in terms of revenue in 2030.
- India is the fastest growing regional market in Asia Pacific and is projected to reach USD 8,841.5 million by 2030.
No credit card required*
Horizon in a snapshot
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
Anti-infective Agents Market Scope
Anti-infective Agents Market Companies
| Name | Profile | # Employees | HQ | Website |
|---|
South Korea anti-infective agents market outlook
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to anti-infective agents market will help companies and investors design strategic landscapes.
Antivirals was the largest segment with a revenue share of 71.85% in 2024. Horizon Databook has segmented the South Korea anti-infective agents market based on antibacterials, antivirals, antifungals covering the revenue growth of each sub-segment from 2018 to 2030.
The anti-infective agents market in South Korea is experiencing notable growth, driven by the rising prevalence of infectious diseases and ongoing advancements in pharmaceutical research and development.
According to the Coalition for Global Hepatitis Elimination, the prevalence of chronic hepatitis B (HBV) in South Korea was reported at 2.69% in 2022, while the prevalence of anti-hepatitis C virus (HCV) stood at 0.66%. These statistics highlight the need for effective anti-infective therapies.
In response, South Korean pharmaceutical companies are heavily investing in research and development, focusing on innovative treatments for viral infections, including hepatitis B and C. This commitment to R&D is expected to enhance the availability of effective anti-infective agents, ultimately improving patient outcomes in the region.
Reasons to subscribe to South Korea anti-infective agents market databook:
-
Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
-
Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
-
Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
-
Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
-
Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.
Target buyers of South Korea anti-infective agents market databook
-
Our clientele includes a mix of anti-infective agents market companies, investment firms, advisory firms & academic institutions.
-
30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
-
Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
-
The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.
Horizon Databook provides a detailed overview of country-level data and insights on the South Korea anti-infective agents market , including forecasts for subscribers. This country databook contains high-level insights into South Korea anti-infective agents market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Partial client list
South Korea anti infective agents market size, by type, 2018-2030 (US$M)
South Korea Anti-infective Agents Market Outlook Share, 2024 & 2030 (US$M)
Related regional statistics
No records
No related regions found.
Sign up - it's easy, and free!
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
